CPT Stock Recent News

Momentum investing is tempting, but value investing in overlooked sectors offers superior long-term returns if you remain disciplined and patient. We share why we think the market may be about to get turned upside down. We also share some of our top picks of the moment.

Key Points With markets still volatile, keep your portfolio protected with high-yielding stocks. Look at real estate investment trusts (REIT), like Mid-Atlantic Apartment Communities, for example. Are you ahead, or behind on retirement? SmartAsset’s free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don’t waste another minute; get started by clicking here.(Sponsor) With markets still volatile, keep your portfolio protected with high-yielding stocks. Look at real estate investment trusts (REIT), like Mid-Atlantic Apartment Communities (NYSE: MAA), for example. With a yield of just over 4%, Mid-Atlantic Apartment Communities is an attractive, oversold opportunity. The REIT focuses on apartment communities in the Southeast, Southwest, and Mid-Atlantic regions of the United States. MAA also declared a quarterly dividend of $1.515 per share, payable on July 31 to sharehol

HOUSTON--(BUSINESS WIRE)--The Board of Trust Managers of Camden Property Trust (NYSE:CPT) (the “Company”) declared a second quarter cash dividend of $1.05 per share to holders of record as of June 30, 2025 of its Common Shares of Beneficial Interest. The dividend is to be paid on July 17, 2025. Camden Property Trust, an S&P 500 Company, is a real estate company primarily engaged in the ownership, management, development, redevelopment, acquisition, and construction of multifamily apartment.

Camden Property Trust is well-positioned for long-term growth as Sun Belt rental markets transition from oversupply to normalization, supporting future rent appreciation. Robust demand persists due to high homeownership costs, driving elevated tenant retention and supporting stable occupancy and rental income. Camden's strong balance sheet, prudent acquisitions, and ongoing development pipeline provide financial flexibility and organic growth opportunities.

Apartment REITs benefit from strong demographic tailwinds, healthy demand, and record-low turnover, supporting stable earnings and dividend growth. This article reviews two Apartment REITs that offer attractive yields, strong balance sheets, and are trading at significant discounts to fair value, with upside potential over the next 2 years. Both boast robust dividend growth, superior profitability, and momentum.

CPT is set to gain from its diverse A/B quality properties, tech upgrades and healthy balance sheet. However, elevated supply and high debt remain headwinds.

HOUSTON--(BUSINESS WIRE)--Camden Property Trust (NYSE:CPT) (the “Company”) announced today it will participate in the Nareit REITweek 2025 Investor Conference on Tuesday, June 3 and Wednesday, June 4, 2025. The Company posted an updated Investor Presentation in conjunction with this event, which includes operating and transactions updates, and is available in the Investors section of the Company's website. In addition to historical information, the Company's Investor Presentation contains forwa.

REITs offer diversified, inflation-hedged income and capital appreciation, making them a compelling addition to any long-term investment portfolio. Current REIT valuations are attractive, with strong growth projected in sectors like data centers, industrial, net lease, and residential properties. I recommend focusing on quality REITs trading below historical multiples, emphasizing margin of safety and reliable dividend growth.

SAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced that the editorial panel of the American Medical Association (AMA) established a new Category I Current Procedural Terminology (CPT®) code for the use of OGM in cytogenomic genome-wide analysis to detect structural and copy number variations related to constitutional genetic disorders. The CPT code is a key component in obtaining reimbursement for the OGM-Dx™ Postnatal Whole Genome SV and OGM-Dx™ Prenatal Whole Genome SV LDTs from third party payers.

When Your REIT Will Cut Its Dividend